A precise definition of primary nonresponse in IBD patients has not been established, nevertheless, an accepted definition with respect to the employment of anti-TNF therapy is a failure to fulfill clinical remission following the induction of a remedy period with documentation of adequate drug levels [11]. This evidence concerns the gene TNF and inflammatory bowel disease.